nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—Parkinson's disease	0.274	0.342	CbGaD
Lurasidone—HTR1A—Parkinson's disease	0.21	0.262	CbGaD
Lurasidone—DRD2—Parkinson's disease	0.178	0.223	CbGaD
Lurasidone—HTR2A—Parkinson's disease	0.138	0.172	CbGaD
Lurasidone—HTR7—enteric nervous system—Parkinson's disease	0.00804	0.0782	CbGeAlD
Lurasidone—HTR7—superior cervical ganglion—Parkinson's disease	0.00769	0.0748	CbGeAlD
Lurasidone—HTR7—myenteric nerve plexus—Parkinson's disease	0.0061	0.0592	CbGeAlD
Lurasidone—HTR7—locus ceruleus—Parkinson's disease	0.00531	0.0516	CbGeAlD
Lurasidone—HTR2A—enteric nervous system—Parkinson's disease	0.00502	0.0488	CbGeAlD
Lurasidone—HTR7—sympathetic nervous system—Parkinson's disease	0.0042	0.0408	CbGeAlD
Lurasidone—HTR2A—myenteric nerve plexus—Parkinson's disease	0.0038	0.0369	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—Parkinson's disease	0.00331	0.0322	CbGeAlD
Lurasidone—HTR7—pons—Parkinson's disease	0.00306	0.0297	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—Parkinson's disease	0.00282	0.0274	CbGeAlD
Lurasidone—HTR2A—cerebellar cortex—Parkinson's disease	0.0027	0.0262	CbGeAlD
Lurasidone—HTR1A—telencephalic ventricle—Parkinson's disease	0.00264	0.0256	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—Parkinson's disease	0.00262	0.0254	CbGeAlD
Lurasidone—HTR7—telencephalic ventricle—Parkinson's disease	0.00252	0.0245	CbGeAlD
Lurasidone—DRD2—telencephalic ventricle—Parkinson's disease	0.00238	0.0231	CbGeAlD
Lurasidone—HTR7—peripheral nervous system—Parkinson's disease	0.00204	0.0198	CbGeAlD
Lurasidone—HTR2A—pons—Parkinson's disease	0.00191	0.0185	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—Parkinson's disease	0.00176	0.0171	CbGeAlD
Lurasidone—HTR7—nerve—Parkinson's disease	0.00159	0.0154	CbGeAlD
Lurasidone—HTR2A—telencephalic ventricle—Parkinson's disease	0.00157	0.0153	CbGeAlD
Lurasidone—DRD2—nerve—Parkinson's disease	0.0015	0.0146	CbGeAlD
Lurasidone—ADRA2A—peripheral nervous system—Parkinson's disease	0.00149	0.0145	CbGeAlD
Lurasidone—HTR2A—peripheral nervous system—Parkinson's disease	0.00127	0.0123	CbGeAlD
Lurasidone—HTR1A—hindbrain—Parkinson's disease	0.00124	0.0121	CbGeAlD
Lurasidone—HTR7—hindbrain—Parkinson's disease	0.00119	0.0116	CbGeAlD
Lurasidone—DRD2—hindbrain—Parkinson's disease	0.00112	0.0109	CbGeAlD
Lurasidone—Ziprasidone—HTR7—Parkinson's disease	0.0011	0.191	CrCbGaD
Lurasidone—Ziprasidone—DRD3—Parkinson's disease	0.00103	0.179	CrCbGaD
Lurasidone—Ziprasidone—DRD1—Parkinson's disease	0.00101	0.176	CrCbGaD
Lurasidone—HTR2A—nerve—Parkinson's disease	0.00099	0.00962	CbGeAlD
Lurasidone—Ziprasidone—HTR1A—Parkinson's disease	0.00084	0.146	CrCbGaD
Lurasidone—HTR2A—hindbrain—Parkinson's disease	0.000741	0.00721	CbGeAlD
Lurasidone—Ziprasidone—DRD2—Parkinson's disease	0.000713	0.124	CrCbGaD
Lurasidone—HTR1A—brainstem—Parkinson's disease	0.000713	0.00693	CbGeAlD
Lurasidone—HTR1A—forebrain—Parkinson's disease	0.000688	0.00669	CbGeAlD
Lurasidone—HTR7—brainstem—Parkinson's disease	0.000681	0.00662	CbGeAlD
Lurasidone—HTR7—forebrain—Parkinson's disease	0.000658	0.00639	CbGeAlD
Lurasidone—DRD2—brainstem—Parkinson's disease	0.000644	0.00626	CbGeAlD
Lurasidone—DRD2—forebrain—Parkinson's disease	0.000622	0.00604	CbGeAlD
Lurasidone—HTR1A—cardiovascular system—Parkinson's disease	0.000582	0.00565	CbGeAlD
Lurasidone—HTR7—cardiovascular system—Parkinson's disease	0.000556	0.0054	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—Parkinson's disease	0.000551	0.0959	CrCbGaD
Lurasidone—Ziprasidone—CYP2D6—Parkinson's disease	0.000504	0.0877	CrCbGaD
Lurasidone—ADRA2A—forebrain—Parkinson's disease	0.000482	0.00469	CbGeAlD
Lurasidone—HTR7—medulla oblongata—Parkinson's disease	0.000475	0.00462	CbGeAlD
Lurasidone—HTR2A—embryo—Parkinson's disease	0.000464	0.00451	CbGeAlD
Lurasidone—HTR1A—midbrain—Parkinson's disease	0.000454	0.00442	CbGeAlD
Lurasidone—HTR1A—spinal cord—Parkinson's disease	0.000443	0.00431	CbGeAlD
Lurasidone—ADRA2C—medulla oblongata—Parkinson's disease	0.000437	0.00424	CbGeAlD
Lurasidone—HTR7—midbrain—Parkinson's disease	0.000434	0.00422	CbGeAlD
Lurasidone—HTR2A—brainstem—Parkinson's disease	0.000425	0.00413	CbGeAlD
Lurasidone—HTR7—spinal cord—Parkinson's disease	0.000424	0.00412	CbGeAlD
Lurasidone—DRD2—midbrain—Parkinson's disease	0.000411	0.00399	CbGeAlD
Lurasidone—HTR2A—forebrain—Parkinson's disease	0.00041	0.00399	CbGeAlD
Lurasidone—ADRA2C—midbrain—Parkinson's disease	0.000399	0.00388	CbGeAlD
Lurasidone—HTR1A—head—Parkinson's disease	0.000394	0.00383	CbGeAlD
Lurasidone—ADRA2C—spinal cord—Parkinson's disease	0.000389	0.00378	CbGeAlD
Lurasidone—HTR7—head—Parkinson's disease	0.000377	0.00366	CbGeAlD
Lurasidone—HTR1A—nervous system—Parkinson's disease	0.000374	0.00363	CbGeAlD
Lurasidone—HTR1A—central nervous system—Parkinson's disease	0.00036	0.0035	CbGeAlD
Lurasidone—HTR7—nervous system—Parkinson's disease	0.000357	0.00347	CbGeAlD
Lurasidone—DRD2—head—Parkinson's disease	0.000356	0.00346	CbGeAlD
Lurasidone—HTR1A—cerebellum—Parkinson's disease	0.000352	0.00342	CbGeAlD
Lurasidone—ADRA2A—medulla oblongata—Parkinson's disease	0.000348	0.00339	CbGeAlD
Lurasidone—HTR2A—cardiovascular system—Parkinson's disease	0.000347	0.00337	CbGeAlD
Lurasidone—ADRA2C—head—Parkinson's disease	0.000346	0.00336	CbGeAlD
Lurasidone—HTR7—central nervous system—Parkinson's disease	0.000344	0.00334	CbGeAlD
Lurasidone—DRD2—nervous system—Parkinson's disease	0.000338	0.00328	CbGeAlD
Lurasidone—HTR7—cerebellum—Parkinson's disease	0.000336	0.00326	CbGeAlD
Lurasidone—ADRA2C—nervous system—Parkinson's disease	0.000328	0.00319	CbGeAlD
Lurasidone—DRD2—central nervous system—Parkinson's disease	0.000325	0.00316	CbGeAlD
Lurasidone—ADRA2A—midbrain—Parkinson's disease	0.000318	0.0031	CbGeAlD
Lurasidone—DRD2—cerebellum—Parkinson's disease	0.000318	0.00309	CbGeAlD
Lurasidone—ADRA2C—central nervous system—Parkinson's disease	0.000316	0.00307	CbGeAlD
Lurasidone—ADRA2A—spinal cord—Parkinson's disease	0.000311	0.00302	CbGeAlD
Lurasidone—ADRA2C—cerebellum—Parkinson's disease	0.000309	0.003	CbGeAlD
Lurasidone—HTR2A—medulla oblongata—Parkinson's disease	0.000296	0.00288	CbGeAlD
Lurasidone—HTR1A—brain—Parkinson's disease	0.000286	0.00277	CbGeAlD
Lurasidone—ADRA2A—head—Parkinson's disease	0.000276	0.00268	CbGeAlD
Lurasidone—HTR7—brain—Parkinson's disease	0.000273	0.00265	CbGeAlD
Lurasidone—HTR2A—midbrain—Parkinson's disease	0.000271	0.00263	CbGeAlD
Lurasidone—HTR2A—spinal cord—Parkinson's disease	0.000264	0.00257	CbGeAlD
Lurasidone—ADRA2A—nervous system—Parkinson's disease	0.000262	0.00254	CbGeAlD
Lurasidone—DRD2—brain—Parkinson's disease	0.000258	0.00251	CbGeAlD
Lurasidone—ADRA2A—central nervous system—Parkinson's disease	0.000252	0.00245	CbGeAlD
Lurasidone—ADRA2C—brain—Parkinson's disease	0.000251	0.00244	CbGeAlD
Lurasidone—ADRA2A—cerebellum—Parkinson's disease	0.000246	0.00239	CbGeAlD
Lurasidone—HTR2A—head—Parkinson's disease	0.000235	0.00228	CbGeAlD
Lurasidone—HTR2A—nervous system—Parkinson's disease	0.000223	0.00216	CbGeAlD
Lurasidone—HTR2A—central nervous system—Parkinson's disease	0.000214	0.00208	CbGeAlD
Lurasidone—HTR2A—cerebellum—Parkinson's disease	0.000209	0.00204	CbGeAlD
Lurasidone—CYP3A4—nervous system—Parkinson's disease	0.000206	0.002	CbGeAlD
Lurasidone—ADRA2A—brain—Parkinson's disease	0.0002	0.00194	CbGeAlD
Lurasidone—CYP3A4—central nervous system—Parkinson's disease	0.000198	0.00193	CbGeAlD
Lurasidone—HTR2A—brain—Parkinson's disease	0.00017	0.00165	CbGeAlD
Lurasidone—ADRA2C—Signaling by GPCR—HTR7—Parkinson's disease	2.52e-05	0.000277	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	2.52e-05	0.000277	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAG—Parkinson's disease	2.51e-05	0.000275	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PENK—Parkinson's disease	2.51e-05	0.000275	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.5e-05	0.000274	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD3—Parkinson's disease	2.49e-05	0.000274	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GSTA4—Parkinson's disease	2.49e-05	0.000274	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	2.49e-05	0.000273	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	2.48e-05	0.000272	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	2.48e-05	0.000272	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—FGB—Parkinson's disease	2.47e-05	0.000271	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.47e-05	0.000271	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR2A—Parkinson's disease	2.46e-05	0.00027	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR1A—Parkinson's disease	2.46e-05	0.00027	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.44e-05	0.000268	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR1A—Parkinson's disease	2.42e-05	0.000266	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TAC1—Parkinson's disease	2.42e-05	0.000266	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GFAP—Parkinson's disease	2.41e-05	0.000265	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GRM4—Parkinson's disease	2.41e-05	0.000264	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GRM5—Parkinson's disease	2.39e-05	0.000262	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TAC1—Parkinson's disease	2.39e-05	0.000262	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD1—Parkinson's disease	2.37e-05	0.00026	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.36e-05	0.000259	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD1—Parkinson's disease	2.34e-05	0.000257	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.33e-05	0.000256	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.33e-05	0.000256	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.33e-05	0.000255	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.3e-05	0.000252	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD3—Parkinson's disease	2.3e-05	0.000252	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	2.29e-05	0.000252	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.29e-05	0.000251	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PENK—Parkinson's disease	2.28e-05	0.00025	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAG—Parkinson's disease	2.28e-05	0.00025	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD3—Parkinson's disease	2.27e-05	0.000249	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR7—Parkinson's disease	2.26e-05	0.000248	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD2—Parkinson's disease	2.26e-05	0.000248	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	2.25e-05	0.000247	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	2.25e-05	0.000247	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PLA2G6—Parkinson's disease	2.25e-05	0.000247	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—EDN1—Parkinson's disease	2.22e-05	0.000244	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MAOB—Parkinson's disease	2.22e-05	0.000244	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.19e-05	0.00024	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.17e-05	0.000238	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.16e-05	0.000237	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	2.16e-05	0.000237	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADRBK1—Parkinson's disease	2.15e-05	0.000236	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	2.13e-05	0.000234	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.12e-05	0.000232	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.1e-05	0.00023	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGF20—Parkinson's disease	2.09e-05	0.00023	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	2.09e-05	0.000229	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PDYN—Parkinson's disease	2.09e-05	0.000229	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD2—Parkinson's disease	2.08e-05	0.000228	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD2—Parkinson's disease	2.05e-05	0.000225	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR7—Parkinson's disease	2.05e-05	0.000225	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CYP2D6—Parkinson's disease	2.03e-05	0.000223	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADORA2A—Parkinson's disease	2.03e-05	0.000223	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.03e-05	0.000223	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ND3—Parkinson's disease	2.02e-05	0.000222	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.02e-05	0.000222	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—EDN1—Parkinson's disease	2.02e-05	0.000222	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.02e-05	0.000221	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.01e-05	0.000221	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CTGF—Parkinson's disease	2e-05	0.000219	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.99e-05	0.000218	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GFAP—Parkinson's disease	1.96e-05	0.000215	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR2A—Parkinson's disease	1.95e-05	0.000214	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	1.94e-05	0.000213	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.94e-05	0.000213	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.9e-05	0.000209	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—OMD—Parkinson's disease	1.9e-05	0.000209	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.9e-05	0.000209	CbGpPWpGaD
Lurasidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.89e-05	0.000208	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INSR—Parkinson's disease	1.87e-05	0.000206	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.87e-05	0.000205	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CYP2E1—Parkinson's disease	1.86e-05	0.000204	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.84e-05	0.000202	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NQO1—Parkinson's disease	1.84e-05	0.000202	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.83e-05	0.000201	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.83e-05	0.000201	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.83e-05	0.0002	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—TH—Parkinson's disease	1.81e-05	0.000199	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.81e-05	0.000199	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.81e-05	0.000198	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.8e-05	0.000198	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.8e-05	0.000198	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.79e-05	0.000197	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FGB—Parkinson's disease	1.77e-05	0.000194	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.77e-05	0.000194	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.77e-05	0.000194	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR1A—Parkinson's disease	1.76e-05	0.000193	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.76e-05	0.000193	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IGF2—Parkinson's disease	1.74e-05	0.000191	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CYCS—Parkinson's disease	1.74e-05	0.000191	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TAC1—Parkinson's disease	1.73e-05	0.00019	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.72e-05	0.000189	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.7e-05	0.000187	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD1—Parkinson's disease	1.7e-05	0.000187	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	1.7e-05	0.000187	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.7e-05	0.000187	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IGF1R—Parkinson's disease	1.68e-05	0.000185	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.67e-05	0.000184	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EDN1—Parkinson's disease	1.66e-05	0.000183	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	1.65e-05	0.000181	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.65e-05	0.000181	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD3—Parkinson's disease	1.65e-05	0.000181	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	1.64e-05	0.00018	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CTGF—Parkinson's disease	1.62e-05	0.000178	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.61e-05	0.000176	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.6e-05	0.000176	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.6e-05	0.000175	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.59e-05	0.000175	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.58e-05	0.000174	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.58e-05	0.000173	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.57e-05	0.000173	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.57e-05	0.000173	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.55e-05	0.00017	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.54e-05	0.000169	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—COMT—Parkinson's disease	1.54e-05	0.000169	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.54e-05	0.000169	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.54e-05	0.000169	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.54e-05	0.000169	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GSTP1—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GBA—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DBH—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MAOA—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NGF—Parkinson's disease	1.53e-05	0.000168	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	1.52e-05	0.000167	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.52e-05	0.000167	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—HMOX1—Parkinson's disease	1.51e-05	0.000166	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	1.51e-05	0.000166	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.49e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NQO1—Parkinson's disease	1.49e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR7—Parkinson's disease	1.49e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD2—Parkinson's disease	1.49e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TH—Parkinson's disease	1.47e-05	0.000162	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.47e-05	0.000161	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	1.46e-05	0.00016	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ABCB1—Parkinson's disease	1.45e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	1.44e-05	0.000158	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	1.43e-05	0.000158	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	1.43e-05	0.000157	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CYCS—Parkinson's disease	1.41e-05	0.000155	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GSTM1—Parkinson's disease	1.41e-05	0.000155	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	1.41e-05	0.000155	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.4e-05	0.000153	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	1.38e-05	0.000152	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.37e-05	0.000151	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—APOE—Parkinson's disease	1.35e-05	0.000149	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.35e-05	0.000148	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GPX1—Parkinson's disease	1.35e-05	0.000148	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	1.34e-05	0.000147	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.33e-05	0.000146	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.33e-05	0.000146	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.29e-05	0.000142	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—COMT—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GSTP1—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MTHFR—Parkinson's disease	1.25e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MAOA—Parkinson's disease	1.24e-05	0.000137	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.23e-05	0.000135	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—HMOX1—Parkinson's disease	1.23e-05	0.000135	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	1.21e-05	0.000133	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	1.21e-05	0.000133	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	0.000133	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	1.19e-05	0.000131	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ABCB1—Parkinson's disease	1.18e-05	0.00013	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—APOE—Parkinson's disease	1.16e-05	0.000127	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—INS—Parkinson's disease	1.16e-05	0.000127	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GSTM1—Parkinson's disease	1.15e-05	0.000126	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.13e-05	0.000124	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.13e-05	0.000124	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DDC—Parkinson's disease	1.13e-05	0.000124	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	1.11e-05	0.000122	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GPX1—Parkinson's disease	1.1e-05	0.00012	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	0.00012	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.1e-05	0.00012	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.08e-05	0.000119	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.08e-05	0.000118	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	1.08e-05	0.000118	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	1.06e-05	0.000117	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.06e-05	0.000117	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	1.04e-05	0.000115	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	1.01e-05	0.000111	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTHFR—Parkinson's disease	1.01e-05	0.000111	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1e-05	0.00011	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGF—Parkinson's disease	9.95e-06	0.000109	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—INS—Parkinson's disease	9.91e-06	0.000109	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	9.81e-06	0.000108	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGF—Parkinson's disease	9.79e-06	0.000107	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	9.7e-06	0.000107	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	9.69e-06	0.000106	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.57e-06	0.000105	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MAOB—Parkinson's disease	9.47e-06	0.000104	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	9.47e-06	0.000104	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOE—Parkinson's disease	9.42e-06	0.000103	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	8.9e-06	9.77e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—Parkinson's disease	8.8e-06	9.66e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—Parkinson's disease	8.66e-06	9.51e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CASP3—Parkinson's disease	8.61e-06	9.45e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INS—Parkinson's disease	8.56e-06	9.4e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—Parkinson's disease	8.55e-06	9.39e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	8.48e-06	9.3e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—Parkinson's disease	8.29e-06	9.1e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—Parkinson's disease	8.05e-06	8.84e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	7.91e-06	8.68e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	7.88e-06	8.65e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—Parkinson's disease	7.52e-06	8.26e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—Parkinson's disease	7.4e-06	8.12e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	7.04e-06	7.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.91e-06	7.59e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—Parkinson's disease	6.73e-06	7.39e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.44e-06	7.07e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	6.38e-06	7e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.37e-06	6.99e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	6.34e-06	6.95e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TH—Parkinson's disease	6.27e-06	6.89e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	6.17e-06	6.77e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	6.13e-06	6.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.02e-06	6.61e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	5.86e-06	6.43e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	5.67e-06	6.23e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CASP3—Parkinson's disease	5.6e-06	6.15e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—Parkinson's disease	5.56e-06	6.11e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	5.51e-06	6.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	5.47e-06	6.01e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—COMT—Parkinson's disease	5.34e-06	5.86e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.31e-06	5.83e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MAOA—Parkinson's disease	5.3e-06	5.82e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	5.24e-06	5.75e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	5.15e-06	5.65e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	5.06e-06	5.56e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—Parkinson's disease	5.05e-06	5.54e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.03e-06	5.52e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	5.01e-06	5.5e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	4.98e-06	5.47e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.88e-06	5.36e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.67e-06	5.13e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	4.61e-06	5.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.31e-06	4.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—Parkinson's disease	4.01e-06	4.41e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—Parkinson's disease	3.74e-06	4.11e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	3.62e-06	3.98e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—Parkinson's disease	3.43e-06	3.77e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.29e-06	3.61e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—Parkinson's disease	3.23e-06	3.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	2.94e-06	3.23e-05	CbGpPWpGaD
